NN is trading 10.42% up at $4.10 in pre-market trading, with no clear company-specific catalyst identified.
- Latest company coverage from August 5–6 highlighted strong second-quarter growth, raised guidance, and refinancing, but is not fresh enough to establish today’s catalyst.
- Broader markets are mixed, while healthcare strength provides limited supporting context for NN’s move.